Purchase Order AG3A94P150041
Award Date 4/7/15
Potential Completion Date 4/30/16
Potential Value $30K
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Athens, GA 30605, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a delivery order valued at $24,830.22 by a civilian federal agency within the Southeast Area on September 15, 2020. This firm fixed-price contract, with an ultimate completion date of October 30, 2020, required delivery of Illumina's sequencing products or services to Athens, Georgia. The contract was issued without set-aside designation, consistent with...
- Illumina, Inc. received a delivery order award valued at $21,441.44 from the Office of the Chief Operating Officer, a civilian federal agency, with an ultimate completion date of September 4, 2015. The contract utilizes firm fixed price pricing and does not employ a set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technologies. Performance of this delivery order took place at Illumina's headquarters location in San Diego, California. As a...
- Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a delivery order contract valued at $246,163.52 by the Office of Administrative Services Procurement Management Branch on November 24, 2020. This firm fixed-price contract (1232SA20D0001) does not utilize a set-aside designation and was completed by March 23, 2021. The contract covers laboratory equipment, consumables, and services for performance in Athens,...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a contract award on March 20, 2018, through a Blanket Purchase Agreement (BPA) call with a civilian federal agency's Southeast Area office. The contract, valued at $8,256.23 with a firm fixed price structure, covers the procurement of Nextera XT DNA Library Preparation Kit, Index Kit, High Output Kit, and PhiX Control Kit—specialized reagent kits essential for...
- Illumina, Inc. was awarded a purchase order by a civilian federal agency for genomic sequencing reagents and consumables valued at $23,623.39. The contract, awarded on December 17, 2018, with an ultimate completion date of December 26, 2018, procures five specific product lines including TruSeq DNA Single Indexes Sets A and B, TruSeq DNA PCR-Free Low Throughput Library Prep Kit, NextSeq 500/550 High Output Kit v2.5, and MiSeq Reagent Kit v2. These products represent core components of Illumina's...
- Illumina, Inc. was awarded a contract valued at $421,838.22 by the Office of Administrative Services Procurement Management Branch to supply Illumina sequencing equipment and related products for the Eastern Laboratory. This contract is executed as a call order under the existing Blanket Purchase Agreement AG-32SC-B-14-0005 on a firm fixed-price basis with no set-aside designation. The award was made on January 9, 2019, with an ultimate completion date of September 9, 2019, and performance is...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a $11,051.04 firm fixed price contract award on June 29, 2016, under a Blanket Purchase Agreement (BPA) call vehicle with the Southeast Area of a civilian federal agency. The contract, designated FC-402-4022, calls for delivery of a High Sequence Rapid SBS Kit V2 (50 Cycles) plus one complementary unit, with an ultimate completion date of September 9, 2019. No...
- Illumina, Inc. was awarded a Firm Fixed Price Purchase Order valued at $21,465.60 by the Pacific West Area, a civilian federal agency, on January 31, 2018, with an ultimate completion date of May 31, 2018. The contract covers an Illumina iSelect Custom Kit for oat genetic analysis, with performance to be completed in San Diego, California. This award was not designated as a set-aside contract, reflecting Illumina's specialized capabilities in genomic sequencing technologies. The contract was...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a Blanket Purchase Agreement (BPA) call valued at $49,428.29 for reagents for sequencing under a civilian federal agency's Northeast Area division. The contract, issued on September 30, 2016, with an ultimate completion date of October 29, 2019, utilized a firm fixed-price structure with no set-aside designation. This award reflects Illumina's specialized...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a $24,814.61 call under a Blanket Purchase Agreement (BPA AG-32SC-B-14-0005) by a civilian federal agency's Southeast Area office on February 9, 2016. The contract, which operated on a firm fixed-price basis with no set-aside designation, was for the delivery of HiSeq Rapid SBS Kit V2 (200 cycles) sequencing reagents. The work was performed at Illumina's San...